Eubel Brady & Suttman Asset Management Inc Charles River Laboratories International, Inc. Transaction History

Eubel Brady & Suttman Asset Management Inc

$766 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 05, 2021	SELL	$372.64 - $458.3 $91,296 - $112,283	-245 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$294.17 - $371.65 $72,071 - $91,054	245 New	245 $71,000

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.14 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$948 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$697 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$397 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$361 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.48B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eubel Brady & Suttman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eubel Brady & Suttman Asset Management Inc with notifications on news.

Account